US Glucose Monitoring Market Analysis
The US has a dominant share in the global diabetes market with 90-95% of the diabetic patients in the country suffering from type-II diabetes. Factors like, high prevalence of diabetes, rising aging population and the increasing incidence of diabetes associated with Western diets have contributed to such stupendous escalation of the diabetes population in the US, further affecting the market for glucose monitoring devices in the country.
According to the report, “US Glucose Monitoring Market Analysis”, the glucose monitoring market in the country is expected to grow at a CAGR of approximately 8% during 2010-2015. Factors, such as steady increase in the number of people diagnosed with diabetes, along with intensive management and treatment processes/procedures are expected to sustain a high market growth rate in the glucose monitoring market. Additionally, from product categories, including blood glucose test strips, monitors, and lancet/lancet devices are expected to register significant growth rates.
Our industry research disclosed that the US market for glucose monitoring is highly competitive. Leading players in the US offering blood glucose monitoring and testing systems include Abbott Diabetes Care, Bayer Healthcare, LifeScan, Medtronic, and Roche Diagnostics. Further, Glucometer DEX, AccuChek, One Touch, and SureStep are some leading brands of the global market.
According to “US Glucose Monitoring Market Analysis”, the US glucose monitoring market was analyzed, by segmenting it into glucose strips, blood glucose meters, continuous glucose meter, and lancets. Each of these sectors have been thoroughly studied and analyzed in the report. Also, the report gives an overview of the patient profile and cost implications of diabetes in the country, which will help customers in determining the future demand scenario.
According to the report, “US Glucose Monitoring Market Analysis”, the glucose monitoring market in the country is expected to grow at a CAGR of approximately 8% during 2010-2015. Factors, such as steady increase in the number of people diagnosed with diabetes, along with intensive management and treatment processes/procedures are expected to sustain a high market growth rate in the glucose monitoring market. Additionally, from product categories, including blood glucose test strips, monitors, and lancet/lancet devices are expected to register significant growth rates.
Our industry research disclosed that the US market for glucose monitoring is highly competitive. Leading players in the US offering blood glucose monitoring and testing systems include Abbott Diabetes Care, Bayer Healthcare, LifeScan, Medtronic, and Roche Diagnostics. Further, Glucometer DEX, AccuChek, One Touch, and SureStep are some leading brands of the global market.
According to “US Glucose Monitoring Market Analysis”, the US glucose monitoring market was analyzed, by segmenting it into glucose strips, blood glucose meters, continuous glucose meter, and lancets. Each of these sectors have been thoroughly studied and analyzed in the report. Also, the report gives an overview of the patient profile and cost implications of diabetes in the country, which will help customers in determining the future demand scenario.
1. ANALYST VIEW
2. RESEARCH METHODOLOGY
3. GLUCOSE MONITORING SYSTEMS: AN INTRODUCTION
4. GLUCOSE MONITORING TECHNOLOGIES
4.1 Enzyme-Photometric Sensing
4.2 Amperometric Sensing
4.3 Fluorescence Technology
4.4 Reverse Iontophoresis
5. MARKET DRIVERS & RESTRAINTS
6. US: DIABETES MARKET OVERVIEW
7. GLUCOSE MONITORING DEVICES MARKET
7.1 Blood Glucose Meter
7.1.1 Market Size
7.1.2 Key Products & Players
7.1.3 Product Introductions
7.2 Continuous Blood Glucose Monitors
7.2.1 Market Size
7.2.2 Key Products & Players
7.3 Glucose Test Strips
7.3.1 Market Size
7.3.2 Key Products & Players
7.4 Lancets
7.4.1 Market Size
7.4.2 Key Products & Players
7.4.3 Product Introductions
8. REGULATORY ENVIRONMENT
9. KEY PLAYERS
9.1 Roche
9.2 LifeScan
9.3 Bayer
9.4 Abbott Laboratories
9.5 Medtronic Diabetes
2. RESEARCH METHODOLOGY
3. GLUCOSE MONITORING SYSTEMS: AN INTRODUCTION
4. GLUCOSE MONITORING TECHNOLOGIES
4.1 Enzyme-Photometric Sensing
4.2 Amperometric Sensing
4.3 Fluorescence Technology
4.4 Reverse Iontophoresis
5. MARKET DRIVERS & RESTRAINTS
6. US: DIABETES MARKET OVERVIEW
7. GLUCOSE MONITORING DEVICES MARKET
7.1 Blood Glucose Meter
7.1.1 Market Size
7.1.2 Key Products & Players
7.1.3 Product Introductions
7.2 Continuous Blood Glucose Monitors
7.2.1 Market Size
7.2.2 Key Products & Players
7.3 Glucose Test Strips
7.3.1 Market Size
7.3.2 Key Products & Players
7.4 Lancets
7.4.1 Market Size
7.4.2 Key Products & Players
7.4.3 Product Introductions
8. REGULATORY ENVIRONMENT
9. KEY PLAYERS
9.1 Roche
9.2 LifeScan
9.3 Bayer
9.4 Abbott Laboratories
9.5 Medtronic Diabetes
LIST OF FIGURES
Figure 6-1: Prevalence of Diabetes (%), 2010 & 2030
Figure 6-2: Number of Diabetic Population (Million), 2010 & 2030
Figure 7-1: Glucose Monitoring Market (Billion US$), 2010-2015
Figure 7-2: Glucose Monitoring Market by Segment (%), 2010
Figure 7-3: Share of Diabetic Population Using Blood Glucose Monitors (2010)
Figure 7-4: Blood Glucose Meter Market (Million US$), 2010-2015
Figure 7-5: Continuous Blood Glucose Monitoring Market (Million US$), 2010-2015
Figure 7-6: Glucose Test Strips Market (Billion US$), 2010-2015
Figure 7-7: Test Strips Prices by Manufacturers (US$ per 100)
Figure 7-8: Lancets Market (Million US$), 2010-2015
Figure 6-1: Prevalence of Diabetes (%), 2010 & 2030
Figure 6-2: Number of Diabetic Population (Million), 2010 & 2030
Figure 7-1: Glucose Monitoring Market (Billion US$), 2010-2015
Figure 7-2: Glucose Monitoring Market by Segment (%), 2010
Figure 7-3: Share of Diabetic Population Using Blood Glucose Monitors (2010)
Figure 7-4: Blood Glucose Meter Market (Million US$), 2010-2015
Figure 7-5: Continuous Blood Glucose Monitoring Market (Million US$), 2010-2015
Figure 7-6: Glucose Test Strips Market (Billion US$), 2010-2015
Figure 7-7: Test Strips Prices by Manufacturers (US$ per 100)
Figure 7-8: Lancets Market (Million US$), 2010-2015
LIST OF TABLES
Table 6-1: Diabetic Patients in Age Group 20-79 Years ('000), 2010 & 2030
Table 6-2: Health Costs on Pre-diabetes/Diabetes by Primary Source of Coverage (Billion US$), 2010 & 2011-2020
Table 6-3: Spending for Pre-diabetes/Diabetes by Federal Government and States (Billion US$), 2011-2020
Table 7-1: List of Blood Glucose Meters by Manufacturers
Table 7-2: Key Continuous Glucose Monitoring Products by Manufacturers (2011)
Table 7-3: Pipeline Products for Continuous Glucose Monitors
Table 7-4: List of Lancets & Lancing Devices by Manufacturers
Table 6-1: Diabetic Patients in Age Group 20-79 Years ('000), 2010 & 2030
Table 6-2: Health Costs on Pre-diabetes/Diabetes by Primary Source of Coverage (Billion US$), 2010 & 2011-2020
Table 6-3: Spending for Pre-diabetes/Diabetes by Federal Government and States (Billion US$), 2011-2020
Table 7-1: List of Blood Glucose Meters by Manufacturers
Table 7-2: Key Continuous Glucose Monitoring Products by Manufacturers (2011)
Table 7-3: Pipeline Products for Continuous Glucose Monitors
Table 7-4: List of Lancets & Lancing Devices by Manufacturers
